Searched for
FREE TREATMENT FOR SMA
Kaynes Technology shares down 26% in 3 days with 10% intraday plunge. Is a sharper correction looming?Kaynes Technology shares continued their three-day decline as investor concerns escalated following Kotak Equities’ report highlighting maj...- Ministries split on drug data exclusivityGovernment ministries are in talks over drug data protection rules. This issue involves domestic drug makers, global pharma giants, and pat...
- India's Got Latent row: Supreme Court raps Samay Raina over disability jokes, asks Center to consider stricter law like SC-ST ActThe Supreme Court urged the Centre to consider a law, similar to the SC-ST Act, to penalize derogatory remarks against persons with disabil...
- Roche Vs Natco: Supreme Court clears decks for launch of Natco Pharma's Risdiplam generic in IndiaThe Supreme Court has allowed Natco Pharma to launch its generic version of the spinal muscular atrophy drug Risdiplam in India, dismissing...
- Roche moves SC against Natco’s launch of generic Risdiplam in IndiaF. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to introduce a g...
- Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche pleaThe Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular a...
- More patients can access key drugs after GST rate cutsRecent GST rate cuts on critical medicines are set to significantly reduce costs for treatments of conditions like multiple myeloma, lung c...
- Roche made over 100 times the cost of a medicine that it sold in India, calculations show; company defends itselfA recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal muscular atrophy (SM...
- SC takes note of plea alleging Samay Raina ridiculed disabledThe Supreme Court is set to examine a plea alleging that Samay Raina, host of "India's Got Latent," ridiculed disabled individuals. The cou...
- Affordable credit, timely payments: MSMEs’ Key Budget DemandsAhead of Budget 2025, experts and industry leaders propose measures to address the $530 billion credit gap facing the MSME sector.
- Spinal Muscular Atrophy: Indira Gandhi Institute to offer free treatment for childrenKarnataka launched free treatment for Spinal Muscular Atrophy (SMA) at the Indira Gandhi Institute of Child Health in Bengaluru. The initia...
- Budget 2024: Here is Finance Minister Nirmala Sitharaman's full budget speech; Click to readBudget 2024: Finance Minister Nirmala Sitharaman presented the Budget for 2024-25, marking her 7th consecutive presentation. This budget is...
- Rs 17 crore for a single dose: Why Zolgensma is world's most expensive medicineThe high cost of Zolgensma, a one-time gene therapy used to treat spinal muscular atrophy (SMA) in children under two, is to limited patien...
- Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottleSince its launch, over 4,000 SMA patients across over 50 countries have benefitted from the drug, Roche said in a statement.
- Don't want Tom, Dick and Harry to collect money: HC on crowdfunding for treatment of rare diseasesJustice P B Suresh Kumar said the court does not want to interdict the crowdfunding process, but it wants the funds to go to the government...
- LPG price hike figures in Rajya SabhaRaising the issue through a zero-hour mention, Jharna Das Baidya said subsidised and non-subsidised LPG prices were raised by a steep Rs 12...
Load More
